Siemens Receives CE Mark for Whole-Body Molecular MR System

Siemens HealthcareSiemens Healthcare announced CE marking for its Biograph mMR system. The CE marking states that the product is assessed before being placed on the market and meets EU safety, clinical benefit and environmental protection requirements. Customers can begin using the new system in Europe for clinical routine application. Biograph mMR is the world's only fully integrated whole-body molecular MR with simultaneous MR and PET data acquisition technology.

Biograph mMR comprises a 3-Tesla magnetic resonance (MR) scanner and an integrated positron emission tomography (PET) detection system with an architecture that performs as one and was designed for uncompromised MR and PET image quality. While MR provides exquisite morphological and functional details in human tissue, PET goes further to investigate at the same time the human body at the level of cellular activity and metabolism. With its simultaneous data acquisition, the innovative system is expected to prove to be particularly valuable in the identification of neurological, oncological and cardiac conditions of disease and in supporting therapy planning. The Biograph mMR also opens new opportunities for research, such as the development of new biomarkers or new therapeutic approaches. Siemens has already installed a number of Biograph mMR systems at customer sites for clinical research, including university hospital Klinikum rechts der Isar of the Munich Technical University, the university hospital of the Eberhard Karls University Tuebingen in Germany, and Massachusetts General Hospital in Boston, USA.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest healthcare solution providers and a leading manufacturer and service provider in the fields of medical imaging, laboratory diagnostics, hospital information technology and hearing instruments. It offers solutions covering the entire supply chain under one roof - from prevention and early detection to diagnosis and on to treatment and aftercare. By optimizing clinical workflows oriented toward the most important clinical pictures, Siemens also strives to make healthcare faster, better and, at the same time, less expensive. Siemens Healthcare currently has some 48,000 employees worldwide and is present throughout the world. During fiscal 2010 (up to September 30) the Sector posted sales worth 12.4 billion euros and profits of around 750 million euros.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...